Stocktoria
SRx Health Solutions, Inc. financials (annual, from 10-K)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.5M | $35.0M | — | $38.6M | $54.7M | $46.0M | $42.6M | $15.6M | $14.8M | $475 |
| Gross profit | $1.5M | $13.0M | — | $11.8M | $15.3M | $15.4M | $16.1M | $5.9M | $7.3M | $264 |
| R&D expense | — | $100,000 | — | $100,000 | $500,000 | $500,000 | $100,000 | — | — | — |
| SG&A expense | $12.9M | $19.0M | — | $24.4M | $35.4M | $28.5M | $34.5M | — | — | — |
| Operating income | -$11.4M | -$6.0M | — | -$21.2M | -$38.8M | -$17.3M | -$27.3M | -$36.3M | -$5.2M | -$527,887 |
| Interest expense | $628,000 | $467,000 | — | $1.4M | $551,000 | — | — | — | — | $532,907 |
| Income tax | — | $9,000 | — | $2,000 | -$18,000 | $37,000 | $0 | $0 | — | $0 |
| Net income | -$45.0M | -$168,000 | -$43.1M | -$22.8M | -$39.3M | $3.4M | -$59.3M | -$184.5M | -$6.0M | -$3.0M |
| EPS (diluted) | $-2.13 | $-0.10 | $-1.95 | $-32.29 | $-58.93 | $0.14 | $-7.26 | — | — | — |
| Operating cash flow | -$8.1M | -$4.4M | -$1.5M | $97,000 | -$20.6M | -$11.9M | -$7.5M | -$21.0M | -$6.9M | -$842,446 |
| Free cash flow | — | -$4.4M | — | $79,000 | -$20.8M | -$12.2M | -$7.7M | -$21.1M | -$6.9M | — |
| Cash & equivalents | $1.3M | $3.1M | $106,000 | $4.5M | $3.2M | $21.7M | $3.9M | $2.4M | $3.9M | $199,674 |
| Inventory | $2.1M | $3.9M | $3.4M | $6.6M | $10.3M | $5.2M | $4.9M | $6.6M | $1.6M | $9,402 |
| Total assets | $8.4M | $15.8M | $33.8M | $16.7M | $38.7M | $74.7M | $51.3M | $53.5M | $6.0M | $209,076 |
| Total liabilities | $8.0M | $7.2M | $88.9M | $13.8M | $17.1M | $16.8M | $79.4M | $50.0M | $9.0M | — |
| Shareholders' equity | $407,000 | -$63.7M | -$55.1M | $2.9M | $21.5M | $57.9M | -$28.1M | -$7.1M | -$3.0M | -$2.6M |
Growth · year-over-year · Revenue CAGR 229.1%
| Metric | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -81.3% | — | — | -29.4% | +18.8% | +8.0% | +173.4% | +5.4% | +3112531.6% | -72.6% |
| Net income growth | — | — | — | — | -1260.8% | — | — | — | — | — |
| EPS growth | — | — | — | — | -42192.9% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001471727 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.